Edward J. Randinitis

1.6k total citations
43 papers, 1.3k citations indexed

About

Edward J. Randinitis is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Pharmacology. According to data from OpenAlex, Edward J. Randinitis has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 12 papers in Oncology and 12 papers in Pharmacology. Recurrent topics in Edward J. Randinitis's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Edward J. Randinitis is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Edward J. Randinitis collaborates with scholars based in United States, New Zealand and China. Edward J. Randinitis's co-authors include Christine Alvey, Allen J. Sedman, Edward L. Posvar, Howard N. Bockbrader, Jack Cook, Artemios B. Vassos, Jeffrey R. Koup, Cho‐Ming Loi, David Wesche and Rebecca A. Boyd and has published in prestigious journals such as JAMA, Neurology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Edward J. Randinitis

43 papers receiving 1.2k citations

Peers

Edward J. Randinitis

PPCH

ONCOL

PMH

PHARM

Achiel Van Peer Belgium

Jan‐Olof Svensson Sweden

R. Dahlqvist Sweden

Ziad Hussein United Kingdom

Mike Ufer Switzerland

Tomonori Tateishi Japan

Jaakko‐Juhani Himberg Finland

Séverine Crettol Switzerland

A. J. J. Wood United States

Nada Božina Croatia

Achiel Van Peer Belgium

Edward J. Randinitis

202 ×0.5

PPCH

202 ×0.8

ONCOL

235 ×1.0

PMH

319 ×1.4

PHARM

208 ×0.9

Citations per year, relative to Edward J. Randinitis Edward J. Randinitis (= 1×) peers Achiel Van Peer

Countries citing papers authored by Edward J. Randinitis

Since Specialization

Citations

This map shows the geographic impact of Edward J. Randinitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward J. Randinitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward J. Randinitis more than expected).

Fields of papers citing papers by Edward J. Randinitis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward J. Randinitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward J. Randinitis. The network helps show where Edward J. Randinitis may publish in the future.

Co-authorship network of co-authors of Edward J. Randinitis

This figure shows the co-authorship network connecting the top 25 collaborators of Edward J. Randinitis. A scholar is included among the top collaborators of Edward J. Randinitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward J. Randinitis. Edward J. Randinitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bramson, Candace, et al.. (2006). A Single‐Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment. The Journal of Clinical Pharmacology. 46(1). 29–36. 12 indexed citations

Ouellet, Danièle, et al.. (2006). Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. British Journal of Clinical Pharmacology. 63(1). 59–66. 17 indexed citations

Bramson, Candace, et al.. (2005). Effect of Lasofoxifene on the Pharmacokinetics of Digoxin in Healthy Postmenopausal Women. The Journal of Clinical Pharmacology. 45(12). 1407–1412. 13 indexed citations

Brodie, Martin J., Elaine A. Wilson, David Wesche, et al.. (2005). Pregabalin Drug Interaction Studies: Lack of Effect on the Pharmacokinetics of Carbamazepine, Phenytoin, Lamotrigine, and Valproate in Patients with Partial Epilepsy. Epilepsia. 46(9). 1407–1413. 87 indexed citations

Powell, J. Robert, Edward J. Randinitis, Jack Cook, & Richard L. Lalonde. (2004). Releasing the Human Spirit in Developing Drugs. International Journal of Pharmaceutical Medicine. 18(1). 13–17. 2 indexed citations

Randinitis, Edward J., Edward L. Posvar, Christine Alvey, et al.. (2003). Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function. The Journal of Clinical Pharmacology. 43(3). 277–283. 182 indexed citations

Ouellet, Danièle, Suzie A. Ferreira, Scott Fountain, et al.. (2003). Pharmacokinetic Interaction of Gabapentin and Naproxen in Rats and Humans. Clinical Pharmacology & Therapeutics. 73(2). 7 indexed citations

Haig, George M., Howard N. Bockbrader, David Wesche, et al.. (2001). Single‐Dose Gabapentin Pharmacokinetics and Safety in Healthy Infants and Children. The Journal of Clinical Pharmacology. 41(5). 507–514. 58 indexed citations

Boyd, Rebecca A., R. H. Stern, Barbra H. Stewart, et al.. (2000). Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated Secretion. The Journal of Clinical Pharmacology. 40(1). 91–98. 139 indexed citations

10.

Loi, Cho‐Ming, Malcolm A. Young, Edward J. Randinitis, Artemios B. Vassos, & Jeffrey R. Koup. (1999). Clinical Pharmacokinetics of Troglitazone. Clinical Pharmacokinetics. 37(2). 91–104. 103 indexed citations

11.

Loi, Cho‐Ming, Christine Alvey, Artemios B. Vassos, et al.. (1999). Steady‐State Pharmacokinetics and Dose Proportionality of Troglitazone and Its Metabolites. The Journal of Clinical Pharmacology. 39(9). 920–926. 46 indexed citations

12.

Loi, Cho‐Ming, Ralph H. Stern, Edward J. Randinitis, et al.. (1998). Effect of Troglitazone on Steady‐State Pharmacokinetics of Digoxin. The Journal of Clinical Pharmacology. 38(2). 178–183. 13 indexed citations

13.

Loi, Cho‐Ming, Christine Alvey, Edward J. Randinitis, et al.. (1997). Meta‐Analysis of Steady‐State Pharmacokinetics of Troglitazone and Its Metabolites. The Journal of Clinical Pharmacology. 37(11). 1038–1047. 22 indexed citations

14.

Loi, Cho‐Ming, Edward J. Randinitis, Artemios B. Vassos, et al.. (1997). Lack of Effect of Type II Diabetes on the Pharmacokinetics of Troglitazone in a Multiple‐Dose Study. The Journal of Clinical Pharmacology. 37(12). 1114–1120. 41 indexed citations

15.

Randinitis, Edward J., et al.. (1991). A High-Performance Liquid Chromatographic Assay for the Enantiomers of Bevantolol in Human Plasma. Pharmaceutical Research. 8(6). 758–762. 11 indexed citations

16.

Digenis, George A., Erik P. Sandefer, Alan Parr, et al.. (1990). Gastrointestinal Behavior of Orally Administered Radiolabeled Erythromycin Pellets in Man as Determined by Gamma Scintigraphy. The Journal of Clinical Pharmacology. 30(7). 621–631. 52 indexed citations

17.

Randinitis, Edward J., R. A. Buchanan, & Arlyn W. Kinkel. (1990). Pharmacokinetic Profile of a 300‐mg Extended Phenytoin Sodium Capsule (Dilantin) Formulation. Epilepsia. 31(4). 458–464. 5 indexed citations

18.

Randinitis, Edward J., Allen J. Sedman, Peter G. Welling, & Arlyn W. Kinkel. (1989). Effect of a High‐Fat Meal on the Bioavailability of a Polymer‐Coated Erythromycin Particle Tablet Formulation. The Journal of Clinical Pharmacology. 29(1). 79–84. 9 indexed citations

19.

Toothaker, Roger D., et al.. (1987). The Influence of Food on the Oral Absorption of Bevantolol. The Journal of Clinical Pharmacology. 27(4). 297–299. 7 indexed citations

20.

Randinitis, Edward J., et al.. (1986). Liquid chromatographic determination of gemfibrozil and its metabolite in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 383(2). 444–448. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact